Table S10 from Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312
Abstract
Table S10 shows the data of in vitro safety panel screening.
Fields of Study & Subjects
Protein Kinase Regulation and GTPase Signaling
Melanoma and MAPK Pathways
Protein Tyrosine Phosphatases
Publication details
- Publication date
- 16 March 2026
- Language
- EN